Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041574105> ?p ?o ?g. }
- W2041574105 endingPage "376" @default.
- W2041574105 startingPage "365" @default.
- W2041574105 abstract "Background: Vasoactivity has hampered progress of hemoglobin-based oxygen carriers (HBOCs) due to concern for adverse blood pressure responses and secondary complications. A recent formulation, highly polymerized HBOC-201 (Biopure, Cambridge, MA), has been found to be less vasoactive than prior less polymerized formulations, and to improve outcome in animal models of hemorrhagic shock (HS) compared with standard resuscitation fluids. HBOCs are envisioned to have life- saving potential for severe trauma patients for whom death due to HS is common despite transport to level I trauma centers. As part of a benefit:risk analysis for a proposed clinical trial of HBOC-201 in patients with traumatic HS, we analyzed data from a previous phase III clinical trial of this HBOC that involved orthopedic surgery patients, for vasoactivity and related effects, with focus on patients more representative of the trauma population. Study Design: In a previous phase III study involving orthopedic surgery patients, HEM-0115, consented/stabilized patients were randomized to receive HBOC-201 (N = 350) (up to ten 30 g Hb units) or red blood cells (RBC) (N = 338) (up to 9 units) at the first transfusion decision. Systolic blood pressure (SBP) responses, key system and individual adverse events (AEs) and serious adverse events, and cardiac biomarker elevation incidences, were compared in the overall population and subpopulations with stable trauma, hypotension, and with age stratification (Student’s t and Fisher’s exact tests, significance p < 0.05). Results: Mild to moderate peak SBP responses were common in HBOC-201 subjects and more common than with RBC in the overall population (mean, 60.8 years old), but less frequent in HBOC-201 subjects with stable trauma, younger age (<50 years old), and hypotension, in whom group differences were narrowed. SBP Δ responses were more common with HBOC-201 than RBC in the overall population, but not in subjects with stable trauma and <50 year olds, in whom response rates were lower. In the overall population, AEs were more common than with RBC in most systems (also, hypertension and stroke); only cardiac system serious adverse events were more common with HBOC-201. In contrast, there were few significant group differences in stable trauma, hypotensive, and <70 and especially <50-year-old subjects, in whom AE incidences were generally lower. A disproportionate number of key AEs occurred in elderly subjects. Troponin (but not CK-MB) elevation was more frequent with HBOC-201 than RBC in the overall population but not in <50 year olds, and was not associated with acute coronary syndrome (ACS) or death. Conclusions: Our limited HEM-0115 safety analysis shows that key potentially vasoactivity-related adverse safety signals were more frequent with HBOC-201 than RBC in older patients undergoing orthopedic surgery with rapid access to safe blood transfusions. That incidences of these safety signals were generally lower and group differences narrowed in subpopulations with stable trauma, hypotension, and younger age, suggests an acceptable safety profile in younger acute trauma populations, especially in settings where rapid access to safe blood transfusions is unavailable; confirmation in controlled clinical trials is urgently warranted." @default.
- W2041574105 created "2016-06-24" @default.
- W2041574105 creator A5007317479 @default.
- W2041574105 creator A5029210221 @default.
- W2041574105 creator A5032069271 @default.
- W2041574105 creator A5036657450 @default.
- W2041574105 creator A5036972585 @default.
- W2041574105 creator A5059555578 @default.
- W2041574105 creator A5083856723 @default.
- W2041574105 creator A5089154408 @default.
- W2041574105 date "2009-02-01" @default.
- W2041574105 modified "2023-09-26" @default.
- W2041574105 title "HBOC-201 Vasoactivity in a Phase III Clinical Trial in Orthopedic Surgery Subjects—Extrapolation of Potential Risk for Acute Trauma Trials" @default.
- W2041574105 cites W1940275730 @default.
- W2041574105 cites W1954558631 @default.
- W2041574105 cites W1968731228 @default.
- W2041574105 cites W1969249273 @default.
- W2041574105 cites W1974718993 @default.
- W2041574105 cites W1978030594 @default.
- W2041574105 cites W1982516608 @default.
- W2041574105 cites W1992775827 @default.
- W2041574105 cites W1999376457 @default.
- W2041574105 cites W2001991494 @default.
- W2041574105 cites W2013004929 @default.
- W2041574105 cites W2016745440 @default.
- W2041574105 cites W2018402959 @default.
- W2041574105 cites W2023760829 @default.
- W2041574105 cites W2037987863 @default.
- W2041574105 cites W2040319167 @default.
- W2041574105 cites W2041704292 @default.
- W2041574105 cites W2044162566 @default.
- W2041574105 cites W2045161311 @default.
- W2041574105 cites W2050557921 @default.
- W2041574105 cites W2057059002 @default.
- W2041574105 cites W2066886380 @default.
- W2041574105 cites W2071704022 @default.
- W2041574105 cites W2075327168 @default.
- W2041574105 cites W2077880275 @default.
- W2041574105 cites W2090699823 @default.
- W2041574105 cites W2096432271 @default.
- W2041574105 cites W2102297330 @default.
- W2041574105 cites W2118464821 @default.
- W2041574105 cites W2121059833 @default.
- W2041574105 cites W2121236256 @default.
- W2041574105 cites W2126109777 @default.
- W2041574105 cites W2129263382 @default.
- W2041574105 cites W2136993609 @default.
- W2041574105 cites W2138516441 @default.
- W2041574105 cites W2144744611 @default.
- W2041574105 cites W2313351478 @default.
- W2041574105 cites W2327567334 @default.
- W2041574105 cites W3022548971 @default.
- W2041574105 cites W4327671694 @default.
- W2041574105 doi "https://doi.org/10.1097/ta.0b013e3181820d5c" @default.
- W2041574105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19204509" @default.
- W2041574105 hasPublicationYear "2009" @default.
- W2041574105 type Work @default.
- W2041574105 sameAs 2041574105 @default.
- W2041574105 citedByCount "40" @default.
- W2041574105 countsByYear W20415741052012 @default.
- W2041574105 countsByYear W20415741052013 @default.
- W2041574105 countsByYear W20415741052014 @default.
- W2041574105 countsByYear W20415741052015 @default.
- W2041574105 countsByYear W20415741052016 @default.
- W2041574105 countsByYear W20415741052017 @default.
- W2041574105 countsByYear W20415741052018 @default.
- W2041574105 countsByYear W20415741052019 @default.
- W2041574105 countsByYear W20415741052020 @default.
- W2041574105 countsByYear W20415741052021 @default.
- W2041574105 countsByYear W20415741052022 @default.
- W2041574105 countsByYear W20415741052023 @default.
- W2041574105 crossrefType "journal-article" @default.
- W2041574105 hasAuthorship W2041574105A5007317479 @default.
- W2041574105 hasAuthorship W2041574105A5029210221 @default.
- W2041574105 hasAuthorship W2041574105A5032069271 @default.
- W2041574105 hasAuthorship W2041574105A5036657450 @default.
- W2041574105 hasAuthorship W2041574105A5036972585 @default.
- W2041574105 hasAuthorship W2041574105A5059555578 @default.
- W2041574105 hasAuthorship W2041574105A5083856723 @default.
- W2041574105 hasAuthorship W2041574105A5089154408 @default.
- W2041574105 hasConcept C126322002 @default.
- W2041574105 hasConcept C141071460 @default.
- W2041574105 hasConcept C197934379 @default.
- W2041574105 hasConcept C2908647359 @default.
- W2041574105 hasConcept C42219234 @default.
- W2041574105 hasConcept C535046627 @default.
- W2041574105 hasConcept C68312169 @default.
- W2041574105 hasConcept C71924100 @default.
- W2041574105 hasConcept C84393581 @default.
- W2041574105 hasConcept C99454951 @default.
- W2041574105 hasConceptScore W2041574105C126322002 @default.
- W2041574105 hasConceptScore W2041574105C141071460 @default.
- W2041574105 hasConceptScore W2041574105C197934379 @default.
- W2041574105 hasConceptScore W2041574105C2908647359 @default.
- W2041574105 hasConceptScore W2041574105C42219234 @default.
- W2041574105 hasConceptScore W2041574105C535046627 @default.
- W2041574105 hasConceptScore W2041574105C68312169 @default.
- W2041574105 hasConceptScore W2041574105C71924100 @default.